Quanterix To Report Second Quarter 2024 Financial Results
Quanterix (NASDAQ: QTRX), a company specializing in ultrasensitive biomarker detection, has announced its plans to report second quarter 2024 financial results. The company will host a conference call on Thursday, August 8, 2024, at 4:30 p.m. E.T. to discuss these results. Prior to the call, Quanterix will issue a press release detailing the Q2 2024 earnings after the market closes on the same day.
Investors can access the live webcast from the News & Events page within the Investors section of the Quanterix website. For those interested in participating, pre-registration links are available for both webcast and audio-only options. An archived webcast replay will be accessible on the company's website for one year following the call.
Quanterix (NASDAQ: QTRX), un'azienda specializzata nella rilevazione di biomarcatori ultrasensibili, ha annunciato i suoi piani per riportare i risultati finanziari del secondo trimestre 2024. L'azienda ospiterà una conferenza telefonica giovedì 8 agosto 2024, alle 16:30 E.T. per discutere questi risultati. Prima della chiamata, Quanterix pubblicherà un comunicato stampa dettagliando gli utili del Q2 2024 dopo la chiusura del mercato nello stesso giorno.
Gli investitori possono accedere alla diretta web dalla pagina Notizie & Eventi all'interno della sezione Investitori del sito web di Quanterix. Per coloro interessati a partecipare, sono disponibili link per la pre-registrazione sia per l'opzione webcast che per quella audio solo. Una ripresa archiviata del webcast sarà accessibile sul sito dell'azienda per un anno dopo la chiamata.
Quanterix (NASDAQ: QTRX), una empresa especializada en la detección de biomarcadores ultrasensibles, ha anunciado sus planes para informar sobre los resultados financieros del segundo trimestre de 2024. La empresa llevará a cabo una llamada de conferencia el jueves 8 de agosto de 2024, a las 4:30 p.m. E.T. para discutir estos resultados. Antes de la llamada, Quanterix emitirá un comunicado de prensa detallando las ganancias del Q2 2024 después del cierre del mercado el mismo día.
Los inversores pueden acceder a la transmisión en vivo desde la página de Noticias y Eventos dentro de la sección de Inversores del sitio web de Quanterix. Para aquellos interesados en participar, hay enlaces de preinscripción disponibles tanto para la opción de webcast como para la opción solo de audio. Se podrá acceder a una repetición archivada del webcast en el sitio de la empresa durante un año después de la llamada.
Quanterix (NASDAQ: QTRX), 초민감 바이오마커 탐지를 전문으로 하는 회사,가 2024년 2분기 재무 결과를 발표할 계획을 발표했습니다. 회사는 2024년 8월 8일 목요일 오후 4시 30분 E.T.에 이 결과에 대해 논의하기 위한 컨퍼런스 콜을 개최합니다. 통화 전에 Quanterix는 같은 날 시장이 닫힌 후 2024년 Q2 수익에 대한 자세한 내용이 담긴 보도자료를 발표할 예정입니다.
투자자는 Quanterix 웹사이트의 투자자 섹션 내 뉴스 및 이벤트 페이지에서 라이브 웹캐스트에 액세스할 수 있습니다. 참여를 원하는 분들을 위해 웹캐스트와 오디오 전용 옵션 모두에 대한 사전 등록 링크가 제공됩니다. 통화 후 1년 동안 회사 웹사이트에서 아카이브된 웹캐스트 재생을 이용할 수 있습니다.
Quanterix (NASDAQ: QTRX), une entreprise spécialisée dans la détection ultrasensible de biomarqueurs, a annoncé ses projets de rapport sur les résultats financiers du deuxième trimestre 2024. L'entreprise organisera une conférence téléphonique le jeudi 8 août 2024, à 16h30 E.T. pour discuter de ces résultats. Avant l'appel, Quanterix publiera un communiqué de presse détaillant les bénéfices du Q2 2024 après la fermeture du marché le même jour.
Les investisseurs peuvent accéder à la diffusion en direct depuis la page Actualités et Événements dans la section Investisseurs du site Web de Quanterix. Pour ceux qui souhaitent participer, des liens de préinscription sont disponibles pour les options de diffusion en direct et audio uniquement. Une répétition archivée de la diffusion en direct sera accessible sur le site de l'entreprise pendant un an après l'appel.
Quanterix (NASDAQ: QTRX), ein Unternehmen, das sich auf die ultrasensible Erkennung von Biomarkern spezialisiert hat, hat seine Pläne angekündigt, die finanziellen Ergebnisse des zweiten Quartals 2024 zu berichten. Das Unternehmen wird am Donnerstag, den 8. August 2024, um 16:30 Uhr E.T. eine Telefonkonferenz abhalten, um diese Ergebnisse zu besprechen. Vor der Konferenz wird Quanterix eine Pressemitteilung herausgeben, in der die Q2 2024-Ergebnisse nach Börsenschluss am selben Tag detailliert werden.
Investoren können den Live-Webcast über die Seite „Nachrichten und Veranstaltungen“ im Bereich „Investoren“ der Quanterix-Website aufrufen. Für Interessierte sind Vorregistrierungslinks für die Optionen Webcast und nur Audio verfügbar. Eine archivierte Webcast-Wiederholung wird ein Jahr lang nach der Konferenz auf der Website des Unternehmens zugänglich sein.
- None.
- None.
Quanterix will issue a press release regarding the second quarter 2024 earnings prior to the conference call on Thursday, August 8, 2024 after the market closes. The press release will be posted on the Quanterix website at https://www.quanterix.com/.
To pre-register for the conference call with a webcast link click here and for an audio only link click here to obtain your dial-in number and passcode. Interested investors can also access the live webcast from the News & Events page within the Investors section of the Quanterix website at https://ir.quanterix.com. An archived webcast replay will be available on the Company’s website for one year.
About Quanterix
From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 2,900 peer-reviewed journals. Find additional information about the
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix’ filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731482322/en/
Media Contact:
PAN Communications
Maya Nimnicht
(510) 334-6273
quanterix@pancomm.com
Investor Relations Contact:
Francis Pruell, Quanterix
(508) 789-1725
ir@quanterix.com
Source: Quanterix Corporation
FAQ
When will Quanterix (QTRX) report its Q2 2024 financial results?
How can investors access Quanterix's (QTRX) Q2 2024 earnings call?
Will there be a replay available for Quanterix's (QTRX) Q2 2024 earnings call?
What is Quanterix's (QTRX) stock exchange and ticker symbol?
